Table 4.
Ratio of geometric mean pharmacokinetic parameters and 90% confidence intervals (anova) based on age, gender, and BMI
| Ratio | |||
|---|---|---|---|
| Pharmacokinetic parameter | Age (Elderly vs. young) | Gender (Male vs. female) | BMI (≤25 kg m−2vs.≥29 kg m−2) |
| Vildagliptin | |||
| Cmax | 1.17 (1.02, 1.35) | 0.90 (0.78, 1.04) | 0.96 (0.83, 1.11) |
| AUC(0,t) | 1.31 (1.18, 1.45) | 0.93 (0.84, 1.03) | 0.90 (0.81, 0.99) |
| AUC(0, ∞) | 1.31 (1.18, 1.45) | 0.93 (0.84, 1.03) | 0.90 (0.81, 0.99) |
| LAY151 | |||
| Cmax | 1.61 (1.41, 1.84) | 0.87 (0.76, 1.00) | 0.99 (0.86, 1.13) |
| AUC(0,t) | 1.70 (1.51, 1.92) | 0.93 (0.82, 1.05) | 0.98 (0.86, 1.11) |
| AUC(0, ∞) | 1.77 (1.56, 2.02) | 0.97 (0.85, 1.10) | 0.95 (0.83, 1.08) |